
Kimera® Labs Receives FDA Phase I/IIa IND Clearance For Its MSC Exosomes Human Study
MIRAMAR, Fla., May 16, 2023 /PRNewswire/ — Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the
Stay informed about the latest advancements at Kimera® Labs Inc. and explore the ever-evolving world of exosomes. From scientific breakthroughs to innovative applications, this page is your gateway to the forefront of regenerative medicine and exosome technology.

MIRAMAR, Fla., May 16, 2023 /PRNewswire/ — Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the

Greg Chernoff* BSc, MD, FRCSC *Corresponding author: Greg Chernoff, BSc, MD, FRCSC; Department of Surgery, Ascension Saint Vincent Hospital, Private Practice, 9002 N Meridian Street,

In an effort to mitigate the effects of the current global pandemic and in compliance with the FDA’s mandate of requiring exosome manufacturers to file

At the South Beach Symposium on advances in modern dermatology in Miami Beach, clinical and scientific researchers from Kimera Labs met with a group of
Physicians and scientists have been researching and developing clinical therapeutics using stem cells for the last half century. The clinical results of these stem cell
Since its inception, Kimera Labs has been dedicated to the production of the purest mesenchymal stem cell (MSC) exosomes in existence. Kimera Labs produces amniotic